call on doc semaglutide Diabetes Drug Could Help Reduce Risk for Cardiovascular Events, Study Finds Doc Talk: Semaglutide & Weight

Loyo, P

[52:57] I think that's a big one that gets misdiagnosed

This reduces common setbacks and helps ensure steady, healthy weight loss

Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products

It could be your blood vessel, or it could be around a nerve. In the release, the FDA highlighted one woman who developed knots on both of her arms one week after receiving unapproved injections